Metsera has accepted Pfizer's $10 billion acquisition offer. This ends a bidding war with rival Novo Nordisk. Pfizer will pay $86.25 per share. Metsera's board recommended shareholders approve the deal. Pfizer aims to strengthen its position in the growing we…
LONDON, April 28 : OPEC and its allies will lose some of their power over the oil market when the United Arab Emirates leaves the group on May 1, but the rest of the producer alliance is likely to stick together and continue to coordinate on oil supply policy, OPEC+ delegates
The City of San Francisco and the Port of Oakland have settled their trademark dispute over the use of "San Francisco" in the Oakland airport's name... Read Full Article →
Aktis Oncology (AKTS) stock is given a "Buy" rating, driven by its innovative miniprotein radioconjugates targeting Nectin-4 and B7-H3 solid tumors. Read the full analysis here. Read Full Article →
Learn how Gen Z can navigate the housing market with financial agility through rate buydowns, ARMs, and down payment assistance programs. Read Full Article →
